Alteration of the microRNA network during the progression of Alzheimer's disease

Pierre Lau(VIB-KU Leuven Center for Cancer Biology), Koen Bossers(Netherlands Institute for Neuroscience), Rekin’s Janky(Centre For Human Genetics), Evgenia Salta(VIB-KU Leuven Center for Cancer Biology), Carlo Sala Frigerio(VIB-KU Leuven Center for Cancer Biology), Shahar Barbash(Edmond and Lily Safra Children's Hospital), Roy Rothman(Edmond and Lily Safra Children's Hospital), Annerieke Sierksma(VIB-KU Leuven Center for Cancer Biology), Amantha Thathiah(VIB-KU Leuven Center for Cancer Biology), David Greenberg(Edmond and Lily Safra Children's Hospital), Aikaterini S. Papadopoulou(VIB-KU Leuven Center for Cancer Biology), Tilmann Achsel(VIB-KU Leuven Center for Cancer Biology), Torik Ayoubi(VIB-KU Leuven Center for Cancer Biology), Hermona Soreq(Edmond and Lily Safra Children's Hospital), Joost Verhaagen(Netherlands Institute for Neuroscience), Dick F. Swaab(Netherlands Institute for Neuroscience), Stein Aerts(Centre For Human Genetics), Bart De Strooper(VIB-KU Leuven Center for Cancer Biology)
EMBO Molecular Medicine
September 9, 2013
Cited by 476Open Access
Full Text

Abstract

An overview of miRNAs altered in Alzheimer's disease (AD) was established by profiling the hippocampus of a cohort of 41 late-onset AD (LOAD) patients and 23 controls, showing deregulation of 35 miRNAs. Profiling of miRNAs in the prefrontal cortex of a second independent cohort of 49 patients grouped by Braak stages revealed 41 deregulated miRNAs. We focused on miR-132-3p which is strongly altered in both brain areas. Downregulation of this miRNA occurs already at Braak stages III and IV, before loss of neuron-specific miRNAs. Next-generation sequencing confirmed a strong decrease of miR-132-3p and of three family-related miRNAs encoded by the same miRNA cluster on chromosome 17. Deregulation of miR-132-3p in AD brain appears to occur mainly in neurons displaying Tau hyper-phosphorylation. We provide evidence that miR-132-3p may contribute to disease progression through aberrant regulation of mRNA targets in the Tau network. The transcription factor (TF) FOXO1a appears to be a key target of miR-132-3p in this pathway.


Related Papers

No related papers found

Powered by citation graph analysis